Missing/wrong data?
Log in to edit
Bortezomib is active in patients with untreated or relapsed Waldenstrom's macroglobulinemia: a phase II study of the National Cancer Institute of Canada Clinical Trials Group
scientific article
Author/s
author: National Cancer Institute of Canada Clinical Trials Group, Edward A. Stadtmauer
Work details
Publication date
March 12, 2007
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.